NLRP3 and diabetes mellitus: These findings indicated that NLRP3 inflammasome suppression could accelerate alveolar bone defect healing in diabetes, which may be associated with repressed proinflammatory cytokine production and enhanced osteogenic gene expression under hyperglycemic conditions.